Microarray expression analysis reveals genetic pathways implicated in C621 synphilin-1-mediated toxicity

Journal of Neural Transmission

Volumn 115, Issue 7, 2008, Pages 941-958

  Bonin, M ^a   Marx, F P ^a   Kautzmann, S ^a   Riess, O ^a   Kruger R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Microarray analysis; Neurodegeneration; Parkinson's disease; Synphilin 1; Tumor growth factor beta

Indexed keywords

ALPHA SYNUCLEIN; COMPLEMENTARY DNA; MUTANT PROTEIN; PARKIN; SYNPHILIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR GROWTH FACTOR BETA1;

ARTICLE; CELL STRESS; CORRELATION ANALYSIS; DNA MICROARRAY; DOPAMINE RELEASE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GERMANY; HUMAN; HUMAN CELL; INGENUITY PATHWAYS ANALYSIS TOOL; LEWY BODY; MOLECULAR MODEL; NEUROBLASTOMA C621 CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WILD TYPE;

EID: 46649116284     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0031-x     Document Type: Article

References (34)

1. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MC, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256-259
2. Castelo-Branco G, Wagner J, Rodriguez FJ, Kele J, Sousa K, Rawal N, Pasolli HA, Fuchs E, Kitajewski J, Arenas E (2003) Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc Natl Acad Sci USA 100:12747-12752
3. Chung KK, Zhang Y, Lim KL, Tanaka Y, Huang H, Gao J, Ross CA, Dawson VL, Dawson TM (2001) Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med 7:1144-1150
4. Engelender S, Kaminsky Z, Guo X, Sharp AH, Amaravi RK, Kleiderlein JJ, Margolis RL, Troncoso JC, Lanahan AA, Worley PF, Dawson VL, Dawson TM, Ross CA (1999) Synphilin-1 associates with alphasynuclein and promotes the formation of cytosolic inclusions. Nat Genet 22:110-114
5. Flanders KC, Ren RF, Lippa CF (1998) Transforming growth factor-betas in neurodegenerative disease. Prog Neurobiol 54:71-85
6. Frautschy SA, Yang F, Calderon L, Cole GM (1996) Rodent models of Alzheimer's disease: rat A beta infusion approaches to amyloid deposits. Neurobiol Aging 17:311-321
7. Giaime E, Sunyach C, Herrant M, Grosso S, Auberger P, McLean PJ, Checler F, da Costa CA (2006) Caspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway. J Biol Chem 281:11515-11522
8. Hicks A, Petursson H, Jonsson T, Stefansson H, Johannsdottir H, Sainz (2002) A susceptibility gene for late-onset idiopathic Parkinson's disease successfully mapped. Ann Neurol 52:549-555
9. Keane MM, Ettenberg SA, Lowrey GA, Russell EK, Lipkowitz S (1996) Fas expression and function in normal and malignant breast cell lines. Cancer Res 56:4791-4798
10. Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
11. Krüger R, Fischer C, Strauss K, Schulte T, Riess O, Epplen JT, Schöls L (2003) Mutations in the neurofilament M gene in Parkinson's disease. Neurosci Lett 351:125-129
12. Lavedan C, Buchholtz S, Nussbaum RL, Albin RL, Polymeropoulos MH (2004) A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration. Neurosci Lett 322:57-61
13. Leroy E, Boyer R, Auburger G, Leube B, Ulm G, Mezey E, Harta G, Brownstein MJ, Jonnalagada S, Chernova T, Dehejia A, Lavedan C, Gasser T, Steinach PJ, Wilkinson KD, Polymeropoulos MH (1998) The ubiquitin pathway in Parkinson's disease. Nature 395:451-452
14. Maraganore DM, Lesnick TG, Elbaz A, Chartier-Harlin MC, Gasser T, Sharma M, Krüger R, Riess O, Hattori N, Mellick GD, Quattrone A, Satoh JI, Toda T, Wang J, Ioannidis JPA, de Andrade M, Rocca WA, theUCH-L1 Global Genetics Consortium (2004) Collaborative reanalysis of the ubiquitin carboxy-terminal hydrolase L1 (UCHL-1) gene S18 variant and its association with Parkinson' s disease (PD). Ann Neurol 55:512-521
15. Maraganore DM, de Andrade M, Elbaz A, Farrer MJ, Ioannidis JP, Krüger R, Rocca WA, Schneider NK, Lesnick TG, Lincoln SJ, Hulihan MM, Aasly JO, Ashizawa T, Chartier-Harlin MC, Checkoway H, Ferrarese C, Hadjigeorgiou G, Hattori N, Kawakami H, Lambert JC, Lynch T, Mellick GD, Papapetropoulos S, Parsian A, Quattrone A, Riess O, Tan EK, Van Broeckhoven C, on behalf of the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium (2006) Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson's disease. JAMA 296:661-670
16. Marx FP, Holzmann C, Strauss KM, Li L, Eberhardt O, Cookson MR, Hernandez D, Farrer MJ, Kachergus J, Engelender S, Ross CA, Berger K, Schöls L, Schulz JB, Riess O, Krüger R (2003) Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet 12:1223-1231
17. Mogi M, Harada M, Kondo T, Narabayashi H, Riederer P, Nagatsu T (1995) Transforming growth factor-beta 1 levels are elevated in the striatum and in ventricular cerebrospinal fluid in Parkinson's disease. Neurosci Lett 193:129-132
18. O'Farrell C, Murphy DD, Petrucelli L, Singleton AB, Hussey J, Farrer M, Hardy J, Dickson DW, Cookson MR (2001) Transfected synphilin-1 forms cytoplasmic inclusions in HEK293 cells. Brain Res Mol Brain Res 97:94-102
19. Oh MK, Scoles DR, Haipek C, Strand AD, Gutmann DH, Olson JM, Pulst SM (2003) Genetic heterogeneity of stably transfected cell lines revealed by expression profiling with oligonucleotide microarrays. J Cell Biochem 90:1068-1078
20. Owen-Schaub L B, Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth A (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 15:3032-3040
21. Pankratz N, Uniacke SK, Halter CA, Rudolph A, Shults CW, Conneally PM, Foroud T, Nichols WC the Parkinson Study Group (2004) Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel loci. Neurology 62:1616-1618
22. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276:2045-2047
23. Prehn JH, Bindokas VP, Jordan J, Galindo MF, Ghadge GD, Roos RP, Boise LH, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, Masterman D, Mastaglia F, Laing NG, Stajich JM, Slotterbeck B, Booze MW, Ribile RC, Rampersaud E, West SG, Gibson RA, Middleton LT, Roses AD, Haines JL, Scott BL, Vance JM, Pericak-Vance MA (2001) Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA 286:2239-2244
24. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, Berg D, Gasser T, Wszolek Z, Müller T, Bornemann A,Wolburg H, Downward J, Riess O, Schulz JB, Krüger R (2005) Loss of function mutations in the gene encoding Omi = HtrA2 in Parkinson's disease. Hum Mol Genet 14:2099-2111
25. Tanaka M, Kim Y M, Lee G, Junn E, Iwatsubo T, Mouradian M M (2004) Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J Biol Chem 279:4625-4631
26. Thompson CB, Krajewski S, Reed JC, Miller RJ (1996) Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49:319-328
27. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MMK, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, Gonzalez-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304:1158-1160
28. van der Wal EA, Gomez-Pinilla F, Cotman CW (1993) Transforming growth factor-beta 1 is in plaques in Alzheimer and down pathologies. Neuroreport 4:69-72
29. Vawter MP, Dillon-Carter O, Tourtellotte WW, Carvey P, Freed WJ (1996) TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol 142:313-322
30. Wang R, Zhang L, Yin D, Mufson A, Shi Y (1998) Protein kinase C regulates Fas (CD95/APO-1) expression. J Immunol 161:2201-207
31. Xu P-Y, Liang R, Jankovic J, Hunter C, Zeng Y-X, Ashizawa T, Lai D, Le WD (2002) Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology 58:881-884
32. Zetterberg H, Andreasen N, Blennow K (2004) Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci Lett 367:194-196
33. Zheng K, Heydari B, Simon DK (2003) A common NURR1 polymorphism associated with Parkinson disease and diffuse Lewy body disease. Arch Neurol 60:722-725
34. Zimprich A, Biskup S, Leitner P, Lichtner P, Farrer M, Lincoln S, Kachergus J, Hulihan M, Uitti R, Calne D (2004) Mutations in LRRK2 Cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601-607